Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NVS compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name
NVS
Novartis AG
Change
Mkt cap
Revenue
Revenue
TAK
Takeda Pharmaceutical Co Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
NVS
Novartis AG
vs
TAK
Takeda Pharmaceutical Co Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NVS
21
REGN
Regeneron Pharmaceuticals
supplier
VEEV
Veeva Systems
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
PTCT
PTC Therapeutics
supplier
17 more · NVS chain
›
Shared
0
No shared counterparties.
Only TAK
17
NBIX
Neurocrine Biosciences
customer
EXEL
Exelixis
supplier
PTGX
Protagonist Therapeutics
supplier
DNLI
Denali Therapeutics
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
13 more · TAK chain
›
NVS
Novartis AG
Change
161.99
▲
+0.04%
· post 162.00
Mkt cap
$310.2B
TAK
Takeda Pharmaceutical Co Ltd
Change
21.01
▼
−0.85%
· post 21.02
Closed
Nov 6 '26
Mkt cap
$36.5B
vs
Compare
Closed
Nov 6 '26
NVS
Novartis AG
vs
TAK
Takeda Pharmaceutical Co Ltd
161.99
▲
+0.04%
post 162.00
Price
21.01
▼
−0.85%
post 21.02
$310.2B
Mkt cap
$36.5B
Change
Change
NVS
161.99
▲
+0.04%
vs
TAK
21.01
▼
−0.85%
Closed
Nov 6 '26